28 Patent Applications for Human Genome Sciences.ROCKVILLE Rockville, city (1990 pop. 44,835), seat of Montgomery co., W central Md., a NW suburb of Washington, D.C.; settled c.1760s, inc. as a city 1860. It has several scientific research and technology laboratories that focus on the aerospace, electronics, nuclear energy, , Md.--(BUSINESS WIRE)--Jan. 27, 1997--Human Genome genome: see genetics. genome all the genetic content contained within an organism. An organism's genome is made up of molecules of deoxyribonucleic acid (DNA) that form long strands that are tightly wound into chromosomes, which are found in the Sciences, Inc. (HGS HGS Human Genome Sciences, Inc. (Rockville, Maryland) HGS Heads Up Guidance System HGS Halifax Grammar School (Halifax, Canada) HGS Hangars HGS Heckmondwike Grammar School (UK) ) today announced that 28 new human genes and their medical uses were published in Europe Europe (y  r`əp), 6th largest continent, c.4,000,000 sq mi (10,360,000 sq km) including adjacent islands (1992 est. pop. 512,000,000). under the International Patent
Convention Treaty (PCT (Private Communications Technology) A protocol from Microsoft that provides secure transactions over the Web. See security protocol. ) in December December: see month. 1996.Each patent application describes a heretofore unknown human gene, and its potential medical uses. Each patent application contains a description of the complete protein sequence and the sequence of the encoding See encode. gene. Each patent application also describes the potential use of the gene itself for diagnostic and therapeutic purpose, and the potential use of the protein to diagnose diagnose /di·ag·nose/ (di´ag-nos) to identify or recognize a disease. di·ag·nose v. 1. To distinguish or identify a disease by diagnosis. 2. , treat and cure disease. One of these newlpatent applications are described in published p atent applications monthly by the entire collection of pharcombined world output on description of new huTo date, HGS has received notice of allowance from the U.S. PTO PTO abbr. 1. Parent Teacher Organization 2. or p.t.o. please turn over 3. power takeoff PTO or pto please turn over Noun 1. on patent applications describing nineteen novel human genes. Four of the nineteen applications have been issued as patents to HGS by the US PTO. The HGS patent portfolio covers a wide range of applications, including the description of a number of proteins that themselves may be useful as drugs (therapeutic proteins drugs), receptors that may be used for discovery of small molecule molecule (mŏl`əky  l) [New Lat.,=little mass], smallest particle of a compound that has all the chemical properties of that compound. drugs, and genes and proteins that may
be useful in the prediction "Prediction is very difficult, especially if it's about the future." - Niels BohrA prediction is a statement or claim that a particular event will occur in the future in more certain terms than a forecast. and diagnosis of cancer and other inherited inherited received by inheritance. inherited achondroplastic dwarfism see achondroplastic dwarfism. inherited combined immunodeficiency see combined immune deficiency syndrome (disease). diseases. "HGS' ability to obtain patent protection on products, particularly therapeutic proteins, is an important element of future success," said Melvin Melvin may refer to one of the following: Name:
The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. of Human Genome Sciences Human Genome Sciences NASDAQ: HGSI is a biopharmaceutical corporation founded in 1992. Its stated purpose is to "discover, develop, manufacture and market innovative drugs that serve patients with unmet medical needs, with a primary focus on protein and antibody drugs. . "We are very pleased with our progress to date. December was a banner Same as banner ad. 1. banner - The title page added to printouts by most print spoolers. Typically includes user or account ID information in very large character-graphics capitals. month." Lists of Human Genome Sciences published PCT patent applications and issued U.S. Patents are appended. Human Genome Sciences, Inc. is a company with the mission to develop products to predict, prevent, detect, treat and cure disease based on technology derived from its leadership position in the discovery and understanding of human, microbial microbial pertaining to or emanating from a microbe. microbial digestion the breakdown of organic material, especially feedstuffs, by microbial organisms. , and plant genes. Human Genome Sciences, Inc. is based in Rockville, Maryland Rockville is the county seat of Montgomery County, Maryland, United States. According to the 2006 census update, the city had a total population of 59,114, making it the second largest city in Maryland. . Any statements released by Human Genome Sciences, Inc. that are forward looking are made pursuant to the safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Editors and investors are cautioned that forward looking statements involve risk and uncertainties which may affect the company's business prospects and performance. These include risks associated with early stage product development, uncertainty that patents will issue and economic, competitive, governmental, technological and other factors discussed in the company's filings with the Securities and Exchange Commission on forms 10K, 10Q and 8K. -0-
HUMAN GENOME SCIENCES, INC.
PCT Published Applications
Title PubNumber PubDate
1. Human Chemokine Beta-8, Chemokine
Beta-1 & Macropphage Inflammatory
Protein-4 (Macrophage Inflammatory
Protein 3 and 4) WO95/17092 29-Jun-1995
2. Haemopietic Maturation Factor WO95/19985 27-Jul-1995
3. Human Growth Hormone WO95/20398 03-Aug-1995
4. Human DNA Mismatch Repair Protein WO95/20678 03-Aug-1995
5. Human Osteoclast Derived Cathepsin WO95/24182 14-Sep-1995
6. Corpuscles of Stannius Protein,
Stanniocalcin WO95/24411 14-Sep-1995
7. Fibroblast Growth Factor-10 WO95/24414 14-Sep-1995
8. Transforming Growth Factor Alpha HI WO95/24466 14-Sep-1995
9. Vascular Endothelial Growth Factor 2 WO95/24473 14-Sep-1995
10. Bone Morphogenic Protein-10 WO95/24474 14-Sep-1995
11. Superoxide Dismutase-4 WO95/27781 19-Oct-1995
12. Human DNase WO95/30428 16-Nov-1995
13. Monocyte Chemotactic Protein-4 WO95/31467 23-Nov-1995
14. Neurotransmitter Transporter WO95/31539 23-Nov-1995
15. Macrophage Migration Inhibitory
Factor-3 WO95/31468 23-Nov-1995
16. Human DNA Topoisomerase I Alpha WO95/31538 23-Nov-1995
17. Human Oxalyl-CoA Decarboxylase WO95/31537 23-Nov-1995
18. Interlrowth Factor-2 WO96/01896 25-Jan-1996
Related
Peptide Receptor WO96/05221 22-Feb-1996
28. Calcitonin Gene Related
Peptide Receptor WO96/04928 2222-Feb-1996
30. Human Chemokine Beta-9 tol Monophosphatose H1 WO96/08557 21-Manzyme
Like Apoptosis Protease-3 and 4 WO96/13603 09-May-1996
40. Tumor Necrosis Factor-Gamma WO96/14328 17-May-1996
41. Human DNA Ligase IV WO96/14394 17-May-1996
42. Human Stanniocalcin-Alpha WO96/15147 23-May-1996
43. Human MutT2 WO96/15222 23-May-1996
44. Human G-Protein Coupled Receptor WO96/16087 30-May-1996
45. Human Choline Acetyltransferase WO96/15806 30-May-1996
46. Human Vascular IBP-Like Growth Factor WO96/17931 13-Jun-1996
47. Human Tissue Inhibitor of
Metalloproteinase-4 WO96/18725 20-Jun-1996
48. Prostatic Growth Factor WO96/18730 20-Jun-1996
49. Human Geranylgeranyl Pyrophosphate
Synthetase WO96/21736 18-Jul-1996
50. Human Deoxycytidine Kinase 2 WO96/21724 18-Jul-1996
51. Human Prostatic Specific Reductase WO96/22360 25-Jul-1996
52. Ubiquitin Conjugating Enzymes 7,8,
and 9 WO96/23410 08-Aug-1996
53. Human Chemokine Beta-11 and Human
Chemokine Alpha-1 WO96/24668 15-Aug-1996
54. Keratinocyte Growth Factor-2 WO96/25422 22-Aug-1996
55. Human G-Protein Coupled Receptor WO96/25432 22-Aug-1996
56. Human Amine Transporter WO96/27009 06-Sep-1996
57. Human Tumor Necrosis Factor
Receptor-Like Genes WO96/28546 19-Sep-1996
58. Human B-Cell Translocation Genes-2
and 3 WO96/29401 26-Sep-1996
59. Human DNA Ligase III WO96/30524 03-Oct-1996
60. Human G-Protein Coupled Receptors WO96/30406 03-Oct-1996
61. Nucleotide Sequence of the Haemophilus
Influenzae Rd Genome, Fragments Thereof,
and Uses Thereof WO96/33276 24-Oct-1996
62. Human Tumor Necrosis Factor Receptors WO96/34095 31-Oct-1996
63. Human Chemokine Beta-8, Chemokine Beta-1
and Macrophage Inflammatory Protein-4 WO96/34891 07-Nov-1996
64. Human Neuropeptide Receptor WO96/34877 07-Nov-1996
65. Human Uridine Diphosphate
Galactose-4-Epimerase WO96/35778 14-Nov-1996
66. Human Inhibitor of Apoptosis Gene 1 WO96/35703 14-Nov-1996
67. Transforming Growth Factor Alpha HII WO96/36709 21-Nov-1996
68. Transforming Growth Factor Alpha HI WO96/39497 12-Dec-1996
69. Vascular Endothelial Growth Factor 2 WO96/39515 12-Dec-1996
70. Therapeutic Compositions and Methods
for Treating Disease States with
Leukocyte Adhesion Inhibitor-1 (LAI-1),
and Chemokine Beta-11 WO96/39522 12-Dec-1996
71. Colon Specific Genes and Proteins WO96/39419 12-Dec-1996
72. Fibroblast Growth Factor-13 WO96/39508 12-Dec-1996
73. Fibroblast Growth Factor-14 WO96/39506 12-Dec-1996
74. Human Chemokine Beta-13 2-Dec-1996
82. Human G-Protein Receptor HIBEF51 WO96/39441 12-Dec-1996
83. Human Amine Receptor WO96/39440 12-Dec-1996
84. Human G-Protein Chemokine Receptor
HDGNR10 WO96/39437 12-Dec-1996
85. Chemokine Beta-12 WO96/39520 12-Dec-1996
86. G-Protein Receptor HTNAD29 WO96/39442 12-Dec-1996
87. G-Protein Receptor HIBEB69 WO96/39438 12-Dec-1996
88. Pineal Gland Specific Gene-1 WO96/39158 12-Dec-1996
89. Bone Morphogenic Protein-10 WO96/39431 12-Dec-1996
90. Human Hepatoma-Derived Growth Factor-2 WO96/39485 12-Dec-1996
91. Natural Killer Cell Enhancing Factor C WO96/39424 12-Dec-1996
92. Human Criptin Growth Factor WO96/39420 12-Dec-1996
93. G-Protein Parathyroid Hormone Receptor
HLTDG74 WO96/39433 12-Dec-1996
94. Human Cystatin E WO96/39418 12-Dec-1996
95. Fibroblast Growth Factor-15 WO96/39509 12-Dec-1996
96. Human Vascular Endothelial Growth
Factor 3 WO96/39421 12-Dec-1996
97. Endothelial-Monocyte Activating
Polypeptide III WO96/40719 19-Dec-1996
U.S. Issued Patents
Title Issue Date Patent No.
1. Macrophage Inflammatory Protein Gamma 17-Sep-1996 5,556,767
2. Human Osteoclast Derived Cathepsin 26-Mar-1996 5,501,969
3. Macrophage Inflammatory Protein 3 and 4 02-Apr-1996 5,504,003
4. Superoxide Dismutase-4 09-Apr-1996 5,506,133
CONTACT: Human Genome Sciences, Inc. Melvin D. Booth or Robert Robert, Henry Martyn 1837-1923. American army engineer and parliamentary authority. He designed the defenses for Washington, D.C., during the Civil War and later wrote Robert's Rules of Order (1876). Noun 1. H. Benson Benson may mean: Places in England:
|
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion